COMPOUND ETHERS FOR TREATMENT OF OPHTHALMOLOGICAL INFLAMMATORY DISEASES Russian patent published in 2018 - IPC A61K9/00 A61K31/21 A61K31/202 A61K31/25 A61P27/00 

FIELD: pharmaceuticals.

SUBSTANCE: invention relates to the pharmaceutical industry and is an ophthalmic product, which is a hermetically packaged aqueous solution, in which a contact lens is placed for storage, comprising a composition containing an ester of an anti-inflammatory lipoid mediator, which is a reaction product of an anti-inflammatory lipoid mediator and a polyol having a chain length of 4 to 10 carbon atoms, where the ester is selected from the group consisting of an esterified polyunsaturated fatty acid selected from Omega-3 and Omega-6 fatty acids, and where the composition contains 10 % by weight or less of an acidic form of an anti-inflammatory lipoid mediator, and where, in addition, the aqueous solution is selected from saline, buffer solution and water.

EFFECT: invention provides the elimination of the problem of eye discomfort due to neo-inorganic essential fatty acids, that is, using esterified analogs of the molecule.

15 cl